B. ÇAKIR, "A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort," EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3, pp.663-664, 2021
ÇAKIR, B. 2021. A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3 , 663-664.
ÇAKIR, B., (2021). A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3, 663-664.
ÇAKIR, BANU. "A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort," EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3, 663-664, 2021
ÇAKIR, BANU. "A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort." EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3, pp.663-664, 2021
ÇAKIR, B. (2021) . "A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort." EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.3, pp.663-664.
@article{article, author={BANU ÇAKIR}, title={A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort}, journal={EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES}, year=2021, pages={663-664} }